7:00 PM - 8:30 PM (Registration and Dinner 6:30 PM - 7:00 PM)
The Grand America Hotel (Grand Ballroom B & C; located on the Lobby Level of Hotel)
555 Main St, Salt Lake City, UT
Breakthroughs in Soft Tissue Sarcoma: Perspectives on Emerging Strategies is a CME-certified live symposium to be held adjunct to the annual sarcoma meeting in Salt Lake City, Utah.
There is a substantial need for improved strategies to manage soft tissue sarcoma (STS). These tumors are heterogeneous malignancies characterized by a complex histology and molecular mutations. Advanced forms of these tumors are especially challenging to manage. Optimal treatment requires a highly skilled, multidisciplinary team including medicine, pathology, radiology, and surgery. Novel strategies for these tumors are in late-stage clinical development and may represent significant steps forward for patients with these most difficult-to-treat tumors. This activity will meet the educational needs of oncology healthcare professionals to keep them up to date on state-of-the-art therapeutic strategies to manage patients with STS.
Please join us and a renowned group of sarcoma experts on Thursday, November 5, from 6:30 pm-8:30 pm to learn about breakthroughs occurring in the treatment and management of STS. This program is not to be missed by clinicians interested in the treatment of this form of cancer.
Key topics on the agenda include:
This educational program is directed toward medical oncologists, surgical oncologists, radiation oncologists, and researchers interested in the treatment of STS. Nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment and management of patients with sarcoma will be invited to participate.
Upon completion of this activity, participants will be able to:
George D. Demetri, MD
Professor of Medicine, Harvard Medical School
Director, Ludwig Center at Harvard
Director, Center for Sarcoma and Bone Oncology
Dana-Farber Cancer Institute
Robin L. Jones, BSc, MB, MRCP, MD (Res)
Royal Marsden Hospital
Team Leader, Sarcoma Clinical Trials
Institute of Cancer Research
William D. Tap, MD
Chief, Sarcoma Medical Oncology Service
Memorial Sloan Kettering Cancer Center
New York, NY
Oncology Briefings™: Updates in Therapeutic Options and Approaches for Tenosynovial Giant Cell Tumors
Apr 28, 2018
April 28, 2018
New York, NY